Hyperlipidemia impairs erectile function in rats by causing cavernosal fibrosis

Area of Science:

• Urology
• Endocrinology
• Cardiovascular Research

Background:

• Hyperlipidemia is a known risk factor for erectile dysfunction (ED).
• The precise mechanisms linking hyperlipidemia to ED remain unclear.
• Understanding these mechanisms is crucial for developing targeted treatments.

Purpose of the Study:

• To investigate the underlying mechanisms of ED in rats induced by hyperlipidemia.
• To evaluate the impact of hyperlipidemia on penile tissue structure and function.
• To explore the roles of apoptosis, autophagy, and fibrosis in hyperlipidemia-associated ED.

Main Methods:

• Rats were fed a high-cholesterol diet for six months to induce hyperlipidemia.
• Erectile function was assessed via cavernous nerve electrostimulation and intracavernosal pressure measurements.
• Penile tissues were analyzed for apoptosis (TUNEL assay), autophagy, fibrosis, and smooth muscle/collagen ratio using immunohistochemistry and Western blotting.

Main Results:

• Hyperlipidemic rats showed significantly elevated plasma lipid levels compared to controls.
• Erectile function was markedly reduced in the hyperlipidemia group.
• Penile tissues exhibited increased fibrosis, elevated apoptosis, decreased autophagy, and a lower smooth muscle/collagen ratio.

Conclusions:

• Hyperlipidemia significantly impairs erectile function in rats.
• The mechanism involves increased cavernosal fibrosis and apoptosis in penile tissue.
• These findings highlight fibrosis as a key factor in hyperlipidemia-induced ED.